>
Zhongzhi Pharmaceutical Holdings logo

3737 - Zhongzhi Pharmaceutical Holdings Share Price

HK$1.27 0.0  0.0%

Last Trade - 09/04/21

Sector
Consumer Defensives
Size
Small Cap
Market Cap £99.9m
Enterprise Value £88.2m
Revenue £178.3m
Position in Universe 3257th / 6085
Bullish
Bearish
Unlock 3737 Revenue
Momentum
Relative Strength (%)
1m -28.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -36.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
688 730.5 944.6 1,142 1,342 1,604 +18.4%
-19.5 -42.0 +29.6 +9.9 +38.2 +25.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, ZhongzhiPharmaceutical Holdings Ltd revenues increased 19% toRMB1.6B. Net income increased 21% to RMB138.5M. Revenuesreflect an increase in demand for the Company's productsand services due to favorable market conditions. Net incomebenefited from FV Adjustments of Financial Investmentsincrease from RMB3.4M to RMB7.5M (income), Gain on disposalof items of property, p increase of 54% to RMB43K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

3737 Revenue Unlock 3737 Revenue

Net Income

3737 Net Income Unlock 3737 Revenue

Normalised EPS

3737 Normalised EPS Unlock 3737 Revenue

PE Ratio Range

3737 PE Ratio Range Unlock 3737 Revenue

Dividend Yield Range

3737 Dividend Yield Range Unlock 3737 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
3737 EPS Forecasts Unlock 3737 Revenue
Profile Summary

Zhongzhi Pharmaceutical Holdings Limited is an investment holding company principally engaged in the pharmaceutical manufacturing in the People’s Republic of China (the PRC) and the operation of chain pharmacies in Zhongshan in the Guangdong province, the PRC. The Company operates its business through two segments: Operation of Chain Pharmacies and Pharmaceutical Manufacturing. Through its subsidiaries, the Company is also engaged in the sales of pharmaceutical drugs and the manufacture and sale of Chinese decoction pieces.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated September 12, 2014
Public Since July 13, 2015
No. of Shareholders: n/a
No. of Employees: 3,303
Sector Consumer Defensives
Industry Food & Drug Retailing
Index
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 840,000,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
3737 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 3737
Upcoming Events for 3737
Tuesday 18th May, 2021 Estimate
Zhongzhi Pharmaceutical Holdings Ltd Annual Shareholders Meeting
Frequently Asked Questions for Zhongzhi Pharmaceutical Holdings
What is the Zhongzhi Pharmaceutical Holdings share price?

As of 09/04/21, shares in Zhongzhi Pharmaceutical Holdings are trading at HK$1.27, giving the company a market capitalisation of £99.9m. This share price information is delayed by 15 minutes.

How has the Zhongzhi Pharmaceutical Holdings share price performed this year?

Shares in Zhongzhi Pharmaceutical Holdings are currently trading at HK$1.27 and the price has moved by 5.83% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Zhongzhi Pharmaceutical Holdings price has moved by -33.18% over the past year.

What are the analyst and broker recommendations for Zhongzhi Pharmaceutical Holdings?

Of the analysts with advisory recommendations for Zhongzhi Pharmaceutical Holdings, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Zhongzhi Pharmaceutical Holdings is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Zhongzhi Pharmaceutical Holdings next release its financial results?

Zhongzhi Pharmaceutical Holdings is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Zhongzhi Pharmaceutical Holdings dividend yield?

Zhongzhi Pharmaceutical Holdings does not currently pay a dividend.

Does Zhongzhi Pharmaceutical Holdings pay a dividend?

Zhongzhi Pharmaceutical Holdings does not currently pay a dividend.

When does Zhongzhi Pharmaceutical Holdings next pay dividends?

Zhongzhi Pharmaceutical Holdings does not currently pay a dividend.

How do I buy Zhongzhi Pharmaceutical Holdings shares?

To buy shares in Zhongzhi Pharmaceutical Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Zhongzhi Pharmaceutical Holdings?

Shares in Zhongzhi Pharmaceutical Holdings are currently trading at HK$1.27, giving the company a market capitalisation of £99.9m.

Where are Zhongzhi Pharmaceutical Holdings shares listed? Where are Zhongzhi Pharmaceutical Holdings shares listed?

Here are the trading details for Zhongzhi Pharmaceutical Holdings:

Country of listing: Hong Kong
Exchange: HKG
Ticker Symbol: 3737
What kind of share is Zhongzhi Pharmaceutical Holdings?

Based on an overall assessment of its quality, value and momentum, Zhongzhi Pharmaceutical Holdings is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Zhongzhi Pharmaceutical Holdings share price forecast 2021?

We were not able to load any forecast data for Zhongzhi Pharmaceutical Holdings.

How can I tell whether the Zhongzhi Pharmaceutical Holdings share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zhongzhi Pharmaceutical Holdings. Over the past six months, the relative strength of its shares against the market has been -39.45%. At the current price of HK$1.27, shares in Zhongzhi Pharmaceutical Holdings are trading at -19.95% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Zhongzhi Pharmaceutical Holdings PE Ratio?

The Zhongzhi Pharmaceutical Holdings PE ratio based on its reported earnings over the past 12 months is 6.4. The shares are currently trading at HK$1.27.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Zhongzhi Pharmaceutical Holdings?

Zhongzhi Pharmaceutical Holdings's management team is headed by:

Tian Lai - CHM
Jiang Li Xia Lai - NED
Jun Cao - DGM
Kwun Wan Ng - NID
Kam Wah Wong - NID
Dai Han Zhou - NID
Mei Fang Jiang - GMG
Wu Yi Li - GMG
Jiong Chen - GMG
Lin Tang - OTH
Jin Le Cheng - EDR
Wing Yan Ho - SEC
Ying Feng Lai - CEO
Ai Xing Yang - NED
Ying Sheng Lai - CFO
Who are the major shareholders of Zhongzhi Pharmaceutical Holdings?

Here are the top five shareholders of Zhongzhi Pharmaceutical Holdings based on the size of their shareholding:

Lai (Zhi Tian) Individual Investor
Percentage owned: 56.22% (472.3m shares)
Advance Keypath Global Investments Ltd. Corporation
Percentage owned: 7.14% (60.0m shares)
Novich Positioning Investment LP Corporation
Percentage owned: 6.08% (51.1m shares)
Jiang (Li Xia) Individual Investor
Percentage owned: 5.03% (42.2m shares)
Lai (Ying Feng) Individual Investor
Percentage owned: 0.71% (5.99m shares)
Similar to 3737
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.